Analyst Price Targets — IVPAF
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 15, 2025 11:44 pm | — | Morgan Stanley | $15.20 | $10.00 | TheFly | Ivanhoe Mines downgraded to Equal Weight from Overweight at Morgan Stanley |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for IVPAF

Ivanhoe Mines Limited is positioned as a long-term value buy due to its several growth projects, and credible expansion into PGM, gold, and nickel. IVPAF's diversification strategy aims to transform it from a copper and zinc producer into a multi-asset, stable miner with a broader revenue base. The company's financial stability and favorable metals market outlook underpin confidence in its ability to execute growth…

Ivanhoe Mines Ltd. (IVPAF) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share.

Ivanhoe Mines' reports Q2 2026 profit of $46M and Adjusted EBITDA of $179M, including $152M of attributable EBITDA from Kamoa-Kakula Kamoa-Kakula's smelter operating costs offset by high-strength sulphuric acid sales during Q2 2026 Sulphuric acid production averaging 1,250+ tonnes per day; Q3 contract prices up >100% this year to ~$840 per tonne H2 2026 Kamoa-Kakula copper production rates set to increase; 2026…

Toronto, Ontario--(Newsfile Corp. - July 22, 2026) - Ivanhoe Mines (TSX: IVN) (OTCQX: IVPAF) will release its 2026 second quarter financial results after market close on Wednesday, July 29, 2026. The company will hold an investor conference call to discuss the results on Thursday, July 30, at 10:30 a.m.

Ivanhoe Mines (OTCMKTS:IVPAF - Get Free Report) and Nexa Resources (NYSE: NEXA - Get Free Report) are both basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, valuation, risk, analyst recommendations and earnings. Analyst Ratings This is a breakdown of
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for IVPAF.
Senate Trading
No Senate trades found for IVPAF.
U.S. House Trading
No House trades found for IVPAF.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
